Mithra Pharmaceuticals

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Castors Development SA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "C2M4E SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "co-CEO",
      "person": {
        "rrn": null,
        "name": "Xavier Paoli",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "co-CEO",
      "person": {
        "rrn": null,
        "name": "CMM\u0026C SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "directeur g\u00E9n\u00E9ral",
      "person": {
        "rrn": null,
        "name": "CEO",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Inge Beernaert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Inge Beernaert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "David Horn Solomon",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Bronzet Management",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Ribono SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Inge Beernaert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Life Science Strategy Consulting SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Gaudeto SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Life Science Strategy Consulting SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Gaudeto SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Inge Beernaert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Ribono SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Castors Development SA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Eva Consulting SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Alius Modi SRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  },
  "legal_form_change": {
    "new": "",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 50212360.13,
      "delta_eur": 20000000.000000004,
      "before_eur": 30212360.13,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Leon Van Rompay",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "David H. Solomon",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "MITHRA PHARMACEUTICALS"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 42891360.13,
      "delta_eur": 7267813.260000005,
      "before_eur": 35623546.87,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-06-27",
    "filing_date": "2023-06-23",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2023-06-21",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0466.526.646",
        "name": "Mithra Pharmaceuticals",
        "role": "contributor",
        "address": "Rue Saint-Georges 5, 4000 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:179",
      "7:181",
      "7:186",
      "7:197",
      "7:198"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "Apport en nature de cr\u00E9ances dues par la soci\u00E9t\u00E9, issues des Conventions Modifi\u00E9es (pr\u00EAts convertibles seniors et accord de conversion), en vue d\u0027une augmentation de capital et d\u0027\u00E9mission de nouvelles actions.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "detected_kind_raw": "capital_shares",
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "person_name": null,
    "org_rep_person_name": "Geoffrey GAUTHY"
  },
  "summary_narrative": "Le conseil d\u0027administration de Mithra Pharmaceuticals a d\u00E9cid\u00E9 d\u0027augmenter le capital de la soci\u00E9t\u00E9 par apport en nature de cr\u00E9ances dues par celle-ci, issues de conventions de pr\u00EAts convertibles et d\u0027accords de conversion conclus avec des fonds g\u00E9r\u00E9s par Highbridge Capital Management et Whitebox Advisors. L\u0027op\u00E9ration, soumise \u00E0 des conditions suspensives, pr\u00E9voit l\u0027\u00E9mission de nouvelles actions en contrepartie de ces apports, dont le nombre et le prix d\u0027\u00E9mission seront d\u00E9termin\u00E9s ult\u00E9rieurement. Le conseil a \u00E9galement nomm\u00E9 un comit\u00E9 charg\u00E9 de mettre en \u0153uvre l\u0027op\u00E9ration, y compris la pr\u00E9para",
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019acte comprenant les procurations, le rapport du CA et le rapport du commissaire.",
    "la coordination des statuts."
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 42824254.0,
      "delta_eur": 2000000.0,
      "before_eur": 40824254.0,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 2500000.8,
      "delta_eur": null,
      "before_eur": null,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 41992326.28,
      "delta_eur": 208947.6099999994,
      "before_eur": 41783378.67,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 41783378.35,
      "delta_eur": 1854570.7199999988,
      "before_eur": 39928807.63,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 36960159.8,
      "delta_eur": 721159.799999997,
      "before_eur": 36239000,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "representant permanent commissaire",
      "person": {
        "rrn": null,
        "name": "Christophe Pelzer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "representant permanent commissaire",
      "person": {
        "rrn": null,
        "name": "C\u00E9dric Antonelli",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "MITHRA PHARMACEUTICALS SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 41227972.15,
      "delta_eur": 8227972.1499999985,
      "before_eur": 33000000,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 41036161.95,
      "delta_eur": 2629403.0500000045,
      "before_eur": 38406758.9,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 40535314.04,
      "delta_eur": 1235314.039999999,
      "before_eur": 39300000,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 40302517.22,
      "delta_eur": 302517.2299999967,
      "before_eur": 39999999.99,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 39438268.05,
      "delta_eur": 223994.08999999613,
      "before_eur": 39214273.96,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 40092606.58,
      "delta_eur": 2147357.710000001,
      "before_eur": 37945248.87,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 39630388.66,
      "delta_eur": 192121.02999999374,
      "before_eur": 39438267.63,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  },
  "legal_form_change": {
    "new": "",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 39187430.09,
      "delta_eur": null,
      "before_eur": null,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 39187430.09,
      "delta_eur": 125581.53000000119,
      "before_eur": 39061848.56,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 39061849.32,
      "delta_eur": 384544.3200000003,
      "before_eur": 38677305.0,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Olivier JACQUES",
    "firm_city": null,
    "firm_name": "GAUTHY \u0026 JACQUES \u2013 Notaires Associ\u00E9s",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-09-28",
    "filing_date": "2022-09-26",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2022-09-22",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [],
    "exchange_ratio": null,
    "legal_articles": [
      "7:180",
      "7:191",
      "7:193"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "La prolongation de la dur\u00E9e des droits de souscription (Droits de Souscription de LDA et Droits de Souscription pour Pr\u00EAt d\u0027Action de Cat\u00E9gories A, B et C) n\u0027implique pas de transfert de patrimoine. Il s\u0027agit d\u0027une simple extension de la p\u00E9riode d\u0027exercice de ces droits, sans modification des conditions initiales.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Olivier JACQUES",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de Mithra Pharmaceuticals, r\u00E9unie le 22 septembre 2022, a approuv\u00E9 la prolongation de deux ans de la dur\u00E9e des droits de souscription \u00E9mis en 2020, tant pour LDA Capital Limited que pour les actionnaires concern\u00E9s par les cat\u00E9gories A, B et C du pr\u00EAt d\u0027actions. Ces d\u00E9cisions n\u0027entra\u00EEnent aucune modification des conditions initiales des droits, mais seulement une extension de leur p\u00E9riode d\u0027exercice, de trois \u00E0 cinq ans.",
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant le PV de carence, les rapports de l\u2019organe d\u2019administration, le rapport du commissaire, la liste de pr\u00E9sence, les avis de participation et les attestation de d\u00E9ten tion",
    "la coordination des statuts"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 39007694.42,
      "delta_eur": 329957.6600000039,
      "before_eur": 38677736.76,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Olivier JACQUES",
    "firm_city": null,
    "firm_name": "GAUTHY \u0026 JACQUES \u2013 Notaires Associ\u00E9s",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-09-28",
    "filing_date": "2022-09-26",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "bijzondere_algemene_vergadering",
    "act_date": "2022-09-22",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0466.526.646",
        "name": "Mithra Pharmaceuticals",
        "role": "other",
        "address": "Rue Saint-Georges 5, 4000 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Selva Luxembourg S.\u00E0.r.l.",
        "role": "other",
        "address": null,
        "is_foreign": true,
        "legal_form": "S.\u00E0.r.l.",
        "is_new_company": false,
        "jurisdiction_country": "LU"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:151"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Aucun transfert de patrimoine n\u0027est effectu\u00E9. L\u0027acte concerne la nomination d\u0027un administrateur et l\u0027approbation de clauses contractuelles li\u00E9es \u00E0 un changement de contr\u00F4le.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "GAUTHY \u0026 JACQUES \u2013 Notaires Associ\u00E9s",
    "person_name": null,
    "org_rep_person_name": "Olivier JACQUES"
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale sp\u00E9ciale des actionnaires de Mithra Pharmaceuticals, r\u00E9unie le 22 septembre 2022, a nomm\u00E9 Selva Luxembourg S.\u00E0.r.l. en tant qu\u0027administrateur pour une dur\u00E9e s\u0027\u00E9tendant jusqu\u0027\u00E0 la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de 2023. Elle a \u00E9galement approuv\u00E9 et ratifi\u00E9 les clauses des conventions li\u00E9es \u00E0 un changement de contr\u00F4le, conform\u00E9ment \u00E0 l\u0027article 7:151 du Code des soci\u00E9t\u00E9s et des associations, et a attribu\u00E9 une procuration sp\u00E9ciale aux administrateurs et aux dirigeants de la soci\u00E9t\u00E9 pour les formalit\u00E9s de publication.",
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant la liste de pr\u00E9sence, les avis de participation et les attestations de d\u00E9tention",
    "proc\u00E8s-verbal de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire du 20 mai 2021",
    "proc\u00E8s-verbal de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire du 19 mai 2022",
    "la coordination des statuts"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "director_changes"
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 38774037.39,
      "delta_eur": 71504.06000000238,
      "before_eur": 38702533.33,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}